文献速递急性肾损伤

尿液生物标志物预测危重症急性肾损伤进展及不良结局

Urinary biomarkers predict progression and adverse outcomes of acute kidney injury in critical illness.
PubMed 文献 · Nephrol Dial Transplant · 2022-01-01

Dublin急性生物标志物组评估研究为前瞻性队列,纳入717例危重症患者,其中186例在入院7天内发生AKI。在早期1-2期AKI时检测14种尿液生物标志物,发现8种与进展独立相关,最佳预测因子为胱抑素C、IL-18、白蛋白和NGAL;这些标志物也与30天内RRT或死亡独立相关。

要点

  • 早期1-2期AKI时尿液胱抑素C、IL-18、白蛋白和NGAL独立预测AKI进展。
  • IL-18、NGAL、白蛋白和MCP-1独立预测30天内RRT或死亡。
  • 上述标志物经进一步验证后可能辅助危重症AKI的诊断与预后评估。

核心结论

  • 在14种新型尿液生物标志物中,胱抑素C、IL-18、白蛋白和NGAL是早期1-2期AKI进展的最佳预测因子。
  • 这些标志物经进一步验证后可能有助于危重症患者AKI的诊断与预后评估及管理。

研究设计与样本

  • Dublin急性生物标志物组评估研究为前瞻性队列研究,纳入717例危重症患者。
  • 主要(诊断)分析评估早期1期或2期AKI时生物标志物水平预测7天内进展至更高AKI分期、肾脏替代治疗(RRT)或死亡的能力。
  • 次要(预后)分析探究生物标志物水平与30天内RRT或死亡的关联。

主要发现

  • 7天内共有186例患者发生AKI。
  • 主要分析中,14种生物标志物中有8种与AKI进展独立相关。
  • 最佳预测因子为胱抑素C(aOR 5.2;95%CI 1.3-23.6)、IL-18(aOR 5.1;95%CI 1.8-15.7)、白蛋白(aOR 4.9;95%CI 1.5-18.3)和NGAL(aOR 4.6;95%CI 1.4-17.9)。
  • ROC和净重分类指数分析同样显示这些生物标志物改善预测。
  • 在1-3期AKI的次要分析中,IL-18、NGAL、白蛋白和单核细胞趋化蛋白-1也与30天内RRT或死亡独立相关。

临床怎么用

  • 对危重症早期1-2期AKI患者,检测尿液胱抑素C、IL-18、白蛋白和NGAL可能帮助识别进展高风险者。
  • 这些标志物经进一步验证后,或可辅助AKI诊断与预后评估并指导管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Acute kidney injury (AKI) is common in hospitalized patients and is associated with high morbidity and mortality. The Dublin Acute Biomarker Group Evaluation study is a prospective cohort study of critically ill patients (n = 717). We hypothesized that novel urinary biomarkers would predict progression of AKI and associated outcomes. METHODS: The primary (diagnostic) analysis assessed the ability of biomarkers levels at the time of early Stage 1 or 2 AKI to predict progression to higher AKI stage, renal replacement therapy (RRT) or death within 7 days of intensive care unit admission. In the secondary (prognostic) analysis, we investigated the association between biomarker levels and RRT or death within 30 days. RESULTS: In total, 186 patients had an AKI within 7 days of admission. In the primary (diagnostic) analysis, 8 of the 14 biomarkers were independently associated with progression. The best predictors were cystatin C [adjusted odds ratio (aOR) 5.2; 95% confidence interval (CI) 1.3-23.6], interleukin-18 (IL-18; aOR 5.1; 95% CI 1.8-15.7), albumin (aOR 4.9; 95% CI 1.5-18.3) and neutrophil gelatinase-associated lipocalin (NGAL; aOR 4.6; 95% CI 1.4-17.9). Receiver-operating characteristics and net reclassification index analyses similarly demonstrated improved prediction by these biomarkers. In the secondary (prognostic) analysis of Stages 1-3 AKI cases, IL-18, NGAL, albumin and monocyte chemotactic protein-1 were also independently associated with RRT or death within 30 days. CONCLUSIONS: Among 14 novel urinary biomarkers assessed, cystatin C, IL-18, albumin and NGAL were the best predictors of Stages 1-2 AKI progression. These biomarkers, after further validation, may have utility to inform diagnostic and prognostic assessment and guide management of AKI in critically ill patients.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Duff S, Irwin R, Cote JM, et al. Urinary biomarkers predict progression and adverse outcomes of acute kidney injury in critical illness. Nephrol Dial Transplant. 2022. PMID: 34491355. doi:10.1093/ndt/gfab263

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。